Business Development

There are two areas of Business Development actively being pursued by the management of Three Rivers Pharmaceuticals, LLC:

Product Licensing (other than US):

AMPHOTEC®/AMPHOCIL®
Amphotericin B Cholesteryl Sulfate
Complex for Injection

AMPHOTEC/AMPHOCIL is an FDA approved lipid form of amphotericin B indicated for the treatment of invasive aspergillosis, a life threatening systemic fungal infection.

It is approved EX US as Amphocil®.

This product is available for out-licensing and distribution, in selected markets

RIBASPHERE®
(ribavirin, USP) CAPSULES
200 mg

RIBASPHERE (Ribavirin capsules) is FDA Approved in combination with INTRON A (interferon alfa-2b, recombinant) Injection for the treatment of chronic hepatitis C in patients 18 years of age and older with compensated liver disease previously untreated with alpha interferon and in patients 18 years of age and older who have relapsed following alpha interferon therapy.

This product is available for out-licensing and distribution, in selected markets

RIBASPHERE®
(ribavirin, USP) TABLETS
200 mg, 400 mg, and 600 mg
Rx Only

RIBASPHERE (Ribavirin tablets) is FDA approved in combination with peginterferon alfa-2a is indicated for the treatment of adults with chronic hepatitis C virus infection who have compensated liver disease and have not been previously treated with interferon alpha. Patients in whom efficacy was demonstrated included patients with compensated liver disease and histological evidence of cirrhosis (Child-Pugh class A).

This product is available for out-licensing and distribution, in selected markets

Acquisition:

Three Rivers Pharmaceuticals is interested in acquiring drugs for infectious diseases, oncology, urology and/or endocrinology specialties.

Three Rivers Pharmaceuticals will entertain all delivery forms and is particularly interested in branded products that are not being promoted.

To initiate discussions for licensing, distribution agreements or products in our acquisition target area, please contact:

Patrick L. Kerrish
Executive Vice President of Business Development
724.778.6013

Three Rivers Pharmaceuticals®
301 Commerce Park
Cranberry Township, PA 16066

Phone Numbers:
800.405.8506 (toll free inside US)
724.778.6100

Business Development: development@3riverspharma.com